Free Trial

Anpario (LON:ANP) Hits New 52-Week High - What's Next?

Anpario logo with Consumer Defensive background

Shares of Anpario plc (LON:ANP - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 437 ($5.35) and last traded at GBX 431.60 ($5.28), with a volume of 124569 shares traded. The stock had previously closed at GBX 407.66 ($4.99).

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group boosted their price objective on Anpario from GBX 340 ($4.16) to GBX 370 ($4.53) and gave the stock a "buy" rating in a report on Wednesday, September 18th.

View Our Latest Research Report on ANP

Anpario Stock Up 5.9 %

The stock has a fifty day moving average price of GBX 359.86 and a two-hundred day moving average price of GBX 321.21. The company has a market cap of £72.98 million, a price-to-earnings ratio of 2,397.78 and a beta of 0.58. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.21.

Insiders Place Their Bets

In related news, insider Karen Prior sold 14,000 shares of the firm's stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.65), for a total value of £53,200 ($65,100.34). Corporate insiders own 30.51% of the company's stock.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Read More

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines